Stock CTLT CATALENT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Catalent, Inc.

Equities

CTLT

US1488061029

Delayed Nyse
Other stock markets
 03:58:45 2024-04-24 pm EDT 		5-day change 1st Jan Change
55.96 USD -0.12% Intraday chart for Catalent, Inc. 0.00% +24.55%
Apr. 12 Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 MT
Apr. 08 Sector Update: Health Care Stocks Decline Late Afternoon MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT)
BU
Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48
MT
Sector Update: Health Care Stocks Decline Late Afternoon
MT
Sector Update: Health Care Stocks Flat to Higher Premarket Monday
MT
Novo Nordisk Parent Resubmits US Antirust Application for Catalent Acquisition
MT
Novo Nordisk parent refiles US application on Catalent deal
RE
Novo Nordisk owner refiles U.S. application for approval of Catalent deal
RE
Invenra Inc. Announces Strategic Collaboration with Catalent to Co-Discover Novel Bispecific ADCs
CI
Cellipont Bioservices Appoints Edwin Beale as Chief Commercial Officer
AQ
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, EVBG, ZFOX
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
PR
Novo Nordisk hopes to launch experimental obesity drug this decade
RE
Transcript : Catalent, Inc. - Special Call
Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment
BU
European stocks hover near record highs at start of busy week
RE
Catalent : Change in Certifying Accountants - Form 8-K
PU
Catalent : Publishes Fifth Annual Corporate Responsibility Report
PU
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Catalent, Inc. - CTLT
PR
CATALENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalent, Inc. - CTLT
BU
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, AXNX, BATL, APA
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTLT Stock
  4. News Catalent, Inc.